amphetamine has been researched along with anandamide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caraballo, I; El Banoua, F; Fernandez-Espejo, E; Ferrer, B; Flores, JA; Galan-Rodriguez, B; Rodriguez de Fonseca, F | 1 |
Di Marzo, V; Hasenöhrl, RU; Molleman, A; Petrosino, S; Thiemann, G; van der Stelt, M | 1 |
Burston, JJ; Wiley, JL | 1 |
3 other study(ies) available for amphetamine and anandamide
Article | Year |
---|---|
Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function.
Topics: Acyltransferases; Amidohydrolases; Amphetamine; Analysis of Variance; Animals; Antiparkinson Agents; Arachidonic Acids; Behavior, Animal; Brain Chemistry; Cell Count; Central Nervous System Stimulants; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Endocannabinoids; Functional Laterality; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Rotation; Serotonin Antagonists; Serotonin Receptor Agonists; Substantia Nigra; Tyrosine 3-Monooxygenase | 2004 |
The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization.
Topics: Amphetamine; Analysis of Variance; Animals; Arachidonic Acids; Behavior, Animal; Cannabinoid Receptor Modulators; Central Nervous System Stimulants; Endocannabinoids; Glycerides; Male; Mice; Mice, Knockout; Motor Activity; Neostriatum; Polyunsaturated Alkamides; Prosencephalon; Receptor, Cannabinoid, CB1; Receptors, Dopamine; Statistics, Nonparametric | 2008 |
Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in rats.
Topics: Age Factors; Amphetamine; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Choice Behavior; Conditioning, Operant; Dopamine Uptake Inhibitors; Dronabinol; Drug Interactions; Endocannabinoids; Male; Muscarinic Antagonists; Polyunsaturated Alkamides; Psychotropic Drugs; Rats; Rats, Long-Evans; Scopolamine; Time Factors | 2010 |